Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
3-hydroxy-3-phenylpropionyl-CoA dehydrogenase, also referred to as phenylhydroxypropionyl-CoA dehydrogenase, is a specialized enzyme primarily identified in plant-associated and anaerobic soil bacteria (Meyer et al., 2018; UniProt Q9KJF2). It plays a pivotal role in the beta-oxidation of aromatic compounds by catalyzing the NAD+-dependent oxidation of 3-hydroxy-3-phenylpropionyl-CoA or its derivatives, such as those produced during ferulic acid degradation, to their corresponding 3-keto (beta-keto) forms. In Agrobacterium fabrum, the enzyme is encoded by the atu1415 gene and is essential for the catabolism of plant-derived hydroxycinnamic acids, a process that facilitates both bacterial nutrition and the detoxification of inhibitory plant phenolics (Meyer et al., 2014; ASM Journals). This metabolic activity is a key determinant in the ecological transition of Agrobacterium from a commensal rhizospheric inhabitant to a virulent pathogen capable of inducing crown-gall tumors in host plants (Meyer et al., 2020; Oxford Academic). Additionally, in anaerobic toluene-degrading bacteria like Thauera aromatica, the enzyme (often termed BbsC as part of the BbsCD complex) is vital for the processing of benzylsuccinate intermediates (Heider et al., 2016; Semantic Scholar). While there are currently no approved clinical drugs targeting this enzyme, it represents a significant target for the development of anti-virulence strategies in agriculture and a valuable biocatalyst in the metabolic engineering of value-added aromatic chemicals such as vanillin.
The enzyme catalyzes the NAD+-dependent oxidation of a 3-hydroxy-phenylpropionyl-CoA ester (or related hydroxycinnamic acid derivatives such as 4-hydroxy-3-methoxyphenyl-beta-hydroxypropionyl-CoA) to its corresponding 3-ketoacyl-CoA (beta-keto) form, which is subsequently cleaved by a thiolase in a beta-oxidation-like pathway.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 3-hydroxy-3-phenylpropionyl-CoA dehydrogenase (BbsC).